RGNT — Regentis Biomaterials Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual cashflow statement for Regentis Biomaterials, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS/A |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.412 | -5.14 | -1.45 | -4.13 | 5.23 |
| Non-Cash Items | 0.142 | 4.42 | 0.068 | 2.2 | -3.84 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.266 | 0.853 | -0.123 | 0.709 | -2.03 |
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Cash from Operating Activities | -0.536 | 0.13 | -1.5 | -1.22 | -0.641 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.5 | 1.24 | 0 | 0.325 | 0.525 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.036 | 1.36 | -1.5 | -0.895 | -0.116 |